APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032

Report ID 173984990220 December 2025198 pages

Choose your research edition.

Industry ResearchDipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors include Boehringer, Bristol-Myers Squibb, AstraZeneca, Glaxo Smith Kline, Pfizer, Eli Lilly, Novo Nordisk and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Company

Boehringer

Bristol-Myers Squibb

AstraZeneca

Glaxo Smith Kline

Pfizer

Eli Lilly

Novo Nordisk

Sanofi

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type

Sitagliptin

Vildagliptin

Saxagliptin

Linagliptin

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application

Hospital

Clinic

Others

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sitagliptin Major Manufacturers Table 3. Vildagliptin Major Manufacturers Table 4. Saxagliptin Major Manufacturers Table 5. Linagliptin Major Manufacturers Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends Table 11. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers Table 12. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges Table 13. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints Table 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2026) Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2027-2032) Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2026) & (K Units) Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2027-2032) & (K Units) Table 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2026) Table 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2027-2032) Table 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers, Product Type & Application Table 32. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2026) Table 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2027-2032) Table 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 42. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 43. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2026) Table 44. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2027-2032) Table 45. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 46. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 47. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2026) Table 51. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2027-2032) Table 52. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 54. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 55. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2026) Table 56. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2027-2032) Table 57. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 59. Boehringer Company Information Table 60. Boehringer Business Overview Table 61. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 63. Boehringer Recent Development Table 64. Bristol-Myers Squibb Company Information Table 65. Bristol-Myers Squibb Business Overview Table 66. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 68. Bristol-Myers Squibb Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Glaxo Smith Kline Company Information Table 75. Glaxo Smith Kline Business Overview Table 76. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 78. Glaxo Smith Kline Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 83. Pfizer Recent Development Table 84. Eli Lilly Company Information Table 85. Eli Lilly Business Overview Table 86. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 88. Eli Lilly Recent Development Table 89. Novo Nordisk Company Information Table 90. Novo Nordisk Business Overview Table 91. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 93. Novo Nordisk Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 98. Sanofi Recent Development Table 99. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 102. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 103. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 108. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 109. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 116. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 117. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 120. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 121. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 124. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 125. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 130. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 131. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 138. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 139. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 142. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 143. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 144. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 146. Nordic Countries Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 147. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 148. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 149. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 150. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 151. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 152. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 153. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 154. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 155. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 156. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 157. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 158. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 162. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 163. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 168. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 169. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 176. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 177. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 180. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 181. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 182. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 183. China Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 188. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 189. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 190. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 191. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 194. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 195. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 196. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 197. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 202. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 203. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 204. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 206. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 207. Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 208. Colombia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 209. Peru Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 211. Israel Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 212. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 213. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 214. Iran Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 215. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List Table 219. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Image Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sitagliptin Image Figure 5. Vildagliptin Image Figure 6. Saxagliptin Image Figure 7. Linagliptin Image Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2032) Figure 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (2021-2032) & (K Units) Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032) Figure 32. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032) Figure 35. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032) Figure 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032) Figure 41. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 42. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 43. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 44. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 45. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 46. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 47. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 48. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 49. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 50. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 51. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 52. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 53. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 54. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 55. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 56. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 57. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 58. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 59. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 60. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 61. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 62. Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 63. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 64. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 65. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 66. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 67. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 68. SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 69. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Sitagliptin
  • Vildagliptin
  • Saxagliptin
  • Linagliptin
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boehringer
  • Bristol-Myers Squibb
  • AstraZeneca
  • Glaxo Smith Kline
  • Pfizer
  • Eli Lilly
  • Novo Nordisk
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Type
  3. 1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sitagliptin
  5. 1.2.3 Vildagliptin
  6. 1.2.4 Saxagliptin
  7. 1.2.5 Linagliptin
  8. 1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Application
  9. 1.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics
  1. 2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends
  2. 2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers
  3. 2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region
  3. 3.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
  9. 3.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers
  6. 4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Tier 1, Tier 2, and Tier 3
5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Type
  1. 5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type
  2. 5.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
  6. 5.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type
6 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Application
  1. 6.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application
  2. 6.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
  6. 6.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Boehringer
  2. 7.1.1 Boehringer Company Information
  3. 7.1.2 Boehringer Business Overview
  4. 7.1.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  6. 7.1.5 Boehringer Recent Developments
  7. 7.2 Bristol-Myers Squibb
  8. 7.2.1 Bristol-Myers Squibb Company Information
  9. 7.2.2 Bristol-Myers Squibb Business Overview
  10. 7.2.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  12. 7.2.5 Bristol-Myers Squibb Recent Developments
  13. 7.3 AstraZeneca
  14. 7.3.1 AstraZeneca Company Information
  15. 7.3.2 AstraZeneca Business Overview
  16. 7.3.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  18. 7.3.5 AstraZeneca Recent Developments
  19. 7.4 Glaxo Smith Kline
  20. 7.4.1 Glaxo Smith Kline Company Information
  21. 7.4.2 Glaxo Smith Kline Business Overview
  22. 7.4.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  24. 7.4.5 Glaxo Smith Kline Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Eli Lilly
  32. 7.6.1 Eli Lilly Company Information
  33. 7.6.2 Eli Lilly Business Overview
  34. 7.6.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  36. 7.6.5 Eli Lilly Recent Developments
  37. 7.7 Novo Nordisk
  38. 7.7.1 Novo Nordisk Company Information
  39. 7.7.2 Novo Nordisk Business Overview
  40. 7.7.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  42. 7.7.5 Novo Nordisk Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type
  2. 8.1.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 8.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application
  6. 8.2.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 8.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country
  10. 8.3.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type
  2. 9.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application
  6. 9.2.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country
  10. 9.3.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type
  2. 10.1.1 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 10.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application
  6. 10.2.1 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type
  2. 11.1.1 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application
  6. 11.2.1 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country
  10. 11.3.1 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type
  2. 12.1.1 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Application
  6. 12.2.1 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country
  10. 12.3.1 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Analysis
  2. 13.1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process
  6. 13.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
  9. 13.2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst